Carcinogenicity Testing and the Evaluation of Regulatory Requirements for Pharmaceuticals
- 1 April 1997
- journal article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 25 (2) , 130-145
- https://doi.org/10.1006/rtph.1997.1085
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Concordance between Rats and Mice in Bioassays for CarcinogenesisRegulatory Toxicology and Pharmacology, 1996
- Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPANature, 1995
- An overview of the Keystone Symposium on Molecular Toxicology, Copper Mountain, Colorado, USA, 9-15 January 1995Human & Experimental Toxicology, 1995
- Transgenic Models of Tumor DevelopmentScience, 1991
- Evaluation of the newborn mouse model for chemical tumorigenesisCarcinogenesis: Integrative Cancer Research, 1991
- Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTPMutation Research/Reviews in Genetic Toxicology, 1991
- A genetic model for colorectal tumorigenesisCell, 1990
- Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7Cell, 1990
- Long‐term assays for carcinogenicityTeratogenesis, Carcinogenesis, and Mutagenesis, 1990
- Interspecies extrapolation in carcinogenesis: prediction between rats and mice.Environmental Health Perspectives, 1989